Selank 10 mg

Back to Products

Price: Original price was: CHF 56.00.Current price is: CHF 39.00.

Selank is a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin. Supplied as a reference material for in-vitro neuropeptide and gene-expression research.

FOR LABORATORY RESEARCH ONLYIntended exclusively for in-vitro laboratory research by qualified professionals. Not approved or intended for human or veterinary use, consumption, or therapeutic applications. See our Research Use Disclaimer.

Description

Overview

Selank consists of the tuftsin sequence (Thr-Lys-Pro-Arg) extended with Pro-Gly-Pro to improve stability against peptidases.

In the laboratory it is used in studies of GABAergic gene expression, enkephalinase inhibition and peptide stability. No claims are made regarding effects in humans or animals.

Typical in-vitro applications

Gene-expression studies in neuronal cell culture
Enkephalin-degrading enzyme inhibition assays
Peptide stability and analytical reference work

Compound data

Compound: Selank
Compound class: Synthetic heptapeptide
Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
Net content: 10 mg per vial (stated for analytical and preparative calculations)
Purity specification: ≥99% (HPLC); measured value on the lot certificate of analysis
Form: Lyophilised powder
Intended use: In-vitro laboratory research only

Storage & handling

Store the sealed vial at −20 °C, dry and protected from light.
Allow the vial to reach room temperature before opening to avoid condensation.
Handle with standard laboratory protective equipment (gloves, lab coat, eye protection).
Shipped at ambient temperature in insulated, tamper-evident packaging.

Analytical documentation

HPLC purity and LC-MS identity are tested for every lot. Certificates of analysis and third-party test reports are published in our COA library on the About Us page.

For laboratory research use only. Not for human or veterinary use. See our Research Use Disclaimer.